Price T Rowe Associates Inc Novo Nordisk A S Call Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,951Shares Held
320MCall Options Held
5.22MPut Options Held
5M-
Jennison Associates LLC21.2MShares$2.28 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.57 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.53 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.44 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.35 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $243B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...